EMvision Medical Devices (ASX: EMV) — Perfil da empresa, notícias e dados financeiros
EMvision Medical Devices is a medical technology company focused on the development and commercialisation of portable electromagnetic brain imaging devices for rapid stroke diagnosis and monitoring.
EMvision Medical Devices
EMvision Medical Devices is a medical technology company focused on the development and commercialisation of portable electromagnetic brain imaging devices for rapid stroke diagnosis and monitoring. The company's proprietary technology utilizes safe, non-ionising electromagnetic waves combined with artificial intelligence algorithms to distinguish between ischemic and haemorrhagic strokes at the point of care. Designed for bedside hospital use and pre-hospital emergency medical services, its neurodiagnostic scanners aim to accelerate critical clinical decision-making and treatment administration. EMvision conducts multi-site clinical trials across major hospitals and health networks to validate its diagnostic hardware and software platforms for emergency care.
Resumo
Operações
Produtos e/ou serviços de EMvision Medical Devices
- Bedside Brain Scanners: Mobile electromagnetic neurodiagnostic imaging systems engineered for point-of-care stroke classification in hospital emergency departments and intensive care units, providing rapid bedside diagnostic scans without requiring patient transport or specialized radiologic shielding infrastructure.
- Pre-Hospital Emergency Units: Ultra-lightweight electromagnetic brain scanners designed for integration into standard road and air ambulance fleets, enabling first responders to conduct rapid pre-hospital neurodiagnostic evaluations and triage patients prior to hospital arrival.
- Diagnostic Signal Algorithms: Artificial intelligence software integrated into proprietary hardware to analyze reflected electromagnetic waves, detect cerebral tissue changes, and classify ischemic versus hemorrhagic stroke types within minutes to assist clinical treatment decisions.
- Clinical Trial Validation: Multi-center clinical studies conducted across major Australian health networks to gather patient scan datasets, validate diagnostic accuracy against conventional computed tomography scans, and support global regulatory clearance submissions.
- Antenna Array Hardware: Flexible electromagnetic sensor headsets and multi-channel radiofrequency hardware engineered to emit low-power, non-ionizing electromagnetic signals safely across diverse patient head sizes without ionizing radiation or ferromagnetism risks.
- Digital Neurodiagnostics Infrastructure: Connected cloud and enterprise data architectures supporting secure scan transmission, automated algorithm processing, diagnostic image management, and seamless remote system integration with hospital electronic health record platforms.
equipe executiva do EMvision Medical Devices
- Scott Philip KirklandCo-founder, CEO, MD & Executive Director
- Karl David PechmannChief Financial Officer
- Forough KhandanChief Technology Officer
- Stuart CrozierChief Scientific Officer & Member of Clinical Advisory Board
- Konstanty BialkowskiHead of Tech Development
- Christian WightHead of Regulatory, Quality & Clinical Operations
- Emma WaldonCompany Secretary
Últimas notícias sobre a EMvision Medical Devices
Principais indicadores financeiros
Resultados divulgados pela EMvision Medical Devices, em AUD.
- Cap. de mercado
- 140,1 mi
- Receita (TTM)
- 8,4 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.1
- Dividend yield
- —
- Margem de lucro
- -99.5%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| — | -16,9 mi | -8,3 mi | |
| 5,1 mi | -8,1 mi | -9,8 mi | |
| 11,2 mi | -1,6 mi | -2,7 mi | |
| 7 mi | -10,9 mi | -3,9 mi |